These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
889 related articles for article (PubMed ID: 17964517)
21. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin. Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951 [TBL] [Abstract][Full Text] [Related]
22. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Yang W; Yan HX; Chen L; Liu Q; He YQ; Yu LX; Zhang SH; Huang DD; Tang L; Kong XN; Chen C; Liu SQ; Wu MC; Wang HY Cancer Res; 2008 Jun; 68(11):4287-95. PubMed ID: 18519688 [TBL] [Abstract][Full Text] [Related]
23. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825 [TBL] [Abstract][Full Text] [Related]
24. Cellular localization and signaling activity of beta-catenin in migrating neural crest cells. de Melker AA; Desban N; Duband JL Dev Dyn; 2004 Aug; 230(4):708-26. PubMed ID: 15254905 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition. Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846 [TBL] [Abstract][Full Text] [Related]
26. Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas. Zucman-Rossi J; Benhamouche S; Godard C; Boyault S; Grimber G; Balabaud C; Cunha AS; Bioulac-Sage P; Perret C Oncogene; 2007 Feb; 26(5):774-80. PubMed ID: 16964294 [TBL] [Abstract][Full Text] [Related]
27. Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. van der Horst G; van der Werf SM; Farih-Sips H; van Bezooijen RL; Löwik CW; Karperien M J Bone Miner Res; 2005 Oct; 20(10):1867-77. PubMed ID: 16160745 [TBL] [Abstract][Full Text] [Related]
28. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798 [TBL] [Abstract][Full Text] [Related]
29. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842 [TBL] [Abstract][Full Text] [Related]
30. Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells. Liao CH; Yeh CT; Huang YH; Wu SM; Chi HC; Tsai MM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Cheng WL; Chen WJ; Lin KH Hepatology; 2012 Mar; 55(3):910-20. PubMed ID: 21994129 [TBL] [Abstract][Full Text] [Related]
31. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver. Kim Y; Sills RC; Houle CD Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069 [TBL] [Abstract][Full Text] [Related]
32. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523 [TBL] [Abstract][Full Text] [Related]
33. Expression of the Wnt inhibitor Dickkopf-1 is required for the induction of neural markers in mouse embryonic stem cells differentiating in response to retinoic acid. Verani R; Cappuccio I; Spinsanti P; Gradini R; Caruso A; Magnotti MC; Motolese M; Nicoletti F; Melchiorri D J Neurochem; 2007 Jan; 100(1):242-50. PubMed ID: 17064353 [TBL] [Abstract][Full Text] [Related]
34. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. Merle P; Kim M; Herrmann M; Gupte A; Lefrançois L; Califano S; Trépo C; Tanaka S; Vitvitski L; de la Monte S; Wands JR J Hepatol; 2005 Nov; 43(5):854-62. PubMed ID: 16098625 [TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor-directed enterocyte proliferation does not induce Wnt pathway transcription. Taylor JA; Bernabe KQ; Guo J; Warner BW J Pediatr Surg; 2007 Jun; 42(6):981-6. PubMed ID: 17560206 [TBL] [Abstract][Full Text] [Related]
36. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma. Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261 [TBL] [Abstract][Full Text] [Related]
37. [Effect of siRNA-mediated beta-catenin gene on Wnt signal pathway in lung adenocarcinoma A549 cell]. Teng Y; Wang XW; Wang YW; Wang J Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):988-92. PubMed ID: 20646651 [TBL] [Abstract][Full Text] [Related]
38. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. Yau TO; Chan CY; Chan KL; Lee MF; Wong CM; Fan ST; Ng IO Oncogene; 2005 Feb; 24(9):1607-14. PubMed ID: 15580286 [TBL] [Abstract][Full Text] [Related]
39. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization. Yin YJ; Katz V; Salah Z; Maoz M; Cohen I; Uziely B; Turm H; Grisaru-Granovsky S; Suzuki H; Bar-Shavit R Cancer Res; 2006 May; 66(10):5224-33. PubMed ID: 16707447 [TBL] [Abstract][Full Text] [Related]
40. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Yu J; Tao Q; Cheng YY; Lee KY; Ng SS; Cheung KF; Tian L; Rha SY; Neumann U; Röcken C; Ebert MP; Chan FK; Sung JJ Cancer; 2009 Jan; 115(1):49-60. PubMed ID: 19051296 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]